…Sweden, Denmark, Norway and Germany, MAX IV and ESS in Sweden, DESY, the European XFEL in Germany, the Medicon Valley Alliance (MVA), industry in MedTech, BioTech and Pharma, Region Skåne, the Capital Region of Denmark and the City of Hamburg. In…
…is therefore crucial for information in DUO to be detailed and accurate for safety review at proposal stage. Post declared sample, gases, chemicals and substances will be reviewed to determine…
Some grand common challenges in certain fields of science have motivated the user community and funding bodies from neighboring countries to develop projects aiming at the design and construction of…
…Tavares, S.C. Leemann, M. Sjöström, Å. Andersson http://dx.doi.org/10.1107/S1600577514011503 Diffraction-limited storage-ring vacuum technology J. Synchrotron Rad., 21, 878-883 (2014) E. Al-Dmour, J. Ahlback, D. Einfeld, P.F. Tavares, M. Grabski http://dx.doi.org/10.1107/S1600577514010480 Magnet design…
The fluid in your gastrointestinal tract is a complex soup of biomolecules. When you take a pharmaceutical drug, the biomolecules may stick to its surface and alter how it’s dissolved…
The study ties in with a reported trend of increased riverine iron concentrations over the last decade in North America, northern Europe and in particular, Swedish and Finnish rivers. This,…
…of plant cell walls with fungal enzymes. The referenced enzyme family contained many unstudied bacterial sequences, and the known enzymes performed unique enzymatic functions for degradation. Larsbrink and colleagues’ succeeding…
…complete application should be submitted through the respective university’s application system. Before writing your application, you can download and read through the Guide for Applicants (Applicants guide.pdf). Please check eligibility criteria before proceeding….
…used X-ray absorption spectroscopy techniques (XANES and EXAFS) at the Balder beamline at MAX IV. Cobalt-toughened cemented carbide inserts coated with a TiAlN compound were prepared as samples. Each contained…
…point. However, current commercial Keap1-targeting drugs covalently inhibit Keap1, a mechanism of action that comes with a lack of selectivity, side effects, and other complications during drug development. “Through this…